LA JOLLA PHARMACEUTICAL CO — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$75.7M

Net Income/Loss (FY2021)

$19.7M

Total Assets (FY2021)

$101.2M

Total Equity (FY2021)

-$66.7M

Cash Flows from Operating Activities (FY2021)

$28.2M

Source: LA JOLLA PHARMACEUTICAL CO 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.